知母皂苷元对痴呆模型大鼠的影响

摘要/Abstract

摘要： 目的建立大鼠β-淀粉样肽[Aβ(25-35)]诱导的痴呆模型,探讨知母总皂苷在阿耳茨海默病(AD)发病机制中的作用。方法 SD大鼠60只,采用脑立体定位技术在大鼠单侧侧脑室一次性注射老化的Aβ(25-35)建立实验性AD模型。手术24h后,大鼠经灌胃分别给予3种剂量的知母总皂苷和EGB761,模型组和空白组给予等剂量的蒸馏水,1次/1d,连续14d。在给予Aβ(25-35)后的第8天,应用Morris水迷宫法测定大鼠的学习记忆功能,造模后第14天断头取脑,测定脑组织超氧化物歧化酶(SOD)、丙二醛(MDA)和总抗氧化能力。结果与空白对照组相比,模型组大鼠空间学习记忆能力明显减弱,寻找平台潜伏期明显延长(P<0.01);脑组织SOD、总抗氧化能力明显降低(P<0.01),而MDA明显升高(P<0.05)。与模型组比较,给予知母总皂苷治疗后的大鼠学习记忆功能障碍得到明显改善,潜伏期显著缩短(P<0.05),SOD活力显著提高(P<0.05),总抗氧化能力也显著增强(P<0.05),MDA水平明显降低(P<0.05)。结论知母总皂苷可明显改善AD模型大鼠的学习记忆功能,同时可提高模型大鼠的抗过氧化能力,这有可能是其改善学习记忆的原因之一。

Abstract: Objective To investigate the effects of timosaponins, one group of the two major components of Anemarrhean asphodeloides Bge, on the learning and memory capacities of rats with dementia induced by amyloid β-peptide(25-35) [Aβ(25-35)]. Methods Sixty SD rats were randomized into 6 groups(n=10) and except for those in the control group, all other rats were subjected to lateral cerebral ventriclar injection of aggregated Aβ(25-35) to prepare rat models of dementia. Twenty-four hours after the injection, the rats received intragastric administration of timosaponins at 3 different doses(treatment group) or Ginkgo biloba extract EGB761 on a daily basis for 14 consecutive days. From postoperative days 8 to 14 after Aβ(25-35) injection, Morris water maze test was performed to evaluate the effects of Aβ(25-35) and the therapeutic agents timosaponins on the learning and memory capacity of the rats. On day 14, the level of malonaldehyde(MDA), superoxide dismutase(SOD) activity and total antioxidation capacity in the brain tissue of the rats were measured. Results Aβ(25-35) induced significant learning and memory impairment in the rats, which had lowered SOD activity and total antioxidation capacity(P<0.01) with elevated MDA level(P<0.05). Compared with the rats in dementia model group, those receiving timosaponin treatment at different doses all manifested alleviation of learning and memory impairment(P<0.05), with enhanced SOD activity(P<0.05) and total antioxidation capacity(P<0.01) and reduced MDA level(P<0.05) in the brain tissue. Conclusion Timosaponins can remarkably enhance the learning and memory capacities in rats with Aβ(25-35)-induced dementia, presumably in relation to their actions to promote the scavenging of the free radicals.

中图分类号:

欧阳石, 孙莉莎, 郭胜蓝, 刘旭, 徐江平. 知母皂苷元对痴呆模型大鼠的影响[J]. 南方医科大学学报, 2005, 25(02): 121-126.

OUYANG Shi, SUN Li-sha, GUO Sheng-lan, LIU Xu, XU Jiang-ping. Effects of timosaponins on learning and memory abilities of rats with dementia induced by lateral cerebral ventricular injection of amyloid β-peptide[J]. Journal of Southern Medical University, 2005, 25(02): 121-126.

参考文献

[1] Selkoe DJ. The molecular pathology of Alzheimer’s disease [J]. Neuron, 1991, 6(4): 487-98.
[2] Loo DT, Copani A, Pike CJ, et al. Apoptosis is induced by β-amyloid in culture central nervous system neurons [J]. Proc Natl Acad Sci USA, 1993, 90(17): 7951-5.
[3] Shearman MS, Ragan CI, Iversen LL. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloidmediated cell death [J]. Proc Natl Acad Sci USA, 1994, 91(4): 1470-4.
[4] Pike C J, Burdick D, Walencewicz A J, et al. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state[J]. J Neurosci, 1993, 13(4): 1676-87.
[5] Yatin SM, Varadarajan S, Butterfield DA. Vitamin E prevents Alzhei mer’s amyloid beta-peptide(1-42)-induced neuronal protein oxidation and reactive oxygen species production [J]. Alzheimer Dis Assoc Disord, 2000, 2(2): 123-31.
[6] Harman D. Ageing: a theory based on free radical and radiation chemistry [J]. Gerontol, 1957(1): 298-300.
[7] Biesalski HK. Free radical theory of aging [J]. Curr Opin Clin Nutr Metab Care, 2002, 5(1): 5-10.
[8] DeFeudis FV, Drieu K. Ginkgo biloba extract(EGb 761) and CNS functions: basic studies and clinical applications [J]. Curr Drug Targets, 2000, 1(1): 25-58.
[9] Smith PF, Maclennan K, Darlington CL. The neuroprotective pro perties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor(PAF)[J]. J Ethnopharmacol,1996, 50(3): 131-9.
[10] Wirth S, Stemmelin J, Will B, et al. Facilitative effects of EGb 761 on olfactory recognition in young and aged rats [J]. Pharmacol Bio chem Behav, 2000, 65(2): 321-6.
[11] Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled,double-blind, randomized trial of an extract of Ginkgo biloba fordementia. North AmericanEGb Study Group [J]. JAMA, 1997, 278(16): 1327-32.
[12] Le Bars PL, Kieser M, Itil KZ. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia[J]. Dement Geriatr Cogn Disord, 2000, 11(4): 230-37.
[13] Christen Y, Maixent JM. What is Ginkgo biloba extract EGb 761? An overview-from molecular biology to clinical medicine [J]. Cell Mol Biol(Noisy-le-grand), 2002, 48(6): 601-11.
[14] DeFeudis FV, Drieu K. Ginkgo biloba extract(EGb 761) and CNS functions: basic studies and clinical applications [J]. Curr Drug Targets 2000, 1(1): 25-58.
[15] Luo Y. Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer’s disease[J]. J Alzheimers Dis, 2001, 3(4): 401-7.
[16] Sastre J, Lloret A, Borras C, et al. Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver[J]. Cell Mol Biol(Noisy-le-grand), 2002, 48(6): 685-92.
[17] 胡雅儿,孙启祥,夏宗勤.ZMS对老年大鼠脑内NGF和BDNF的影响[J].中国药理学通报,2003,19(2):149-51.Hu YE, Sun QX, Xia ZQ. The effect of ZMS, an active component of Zhimu, on NGF and BDNF in brains of aged rats [J]. Chin Pharmacol Bull, 2003, 19(2): 149-51.
[18] 徐江平. 知母皂苷对衰大鼠 M、N胆碱受体的调节作用 [J]. 中国老年杂志, 2001, 21: 379-80.Xu JP. Regulation of saponins from Anemarrhean Asphodeloides Bge on cerebral M, N-acetylchol in receptors in aged rats[J]. Chin J Gerontol, 2001, 21: 379-80.
[19] Kaname N, Zhang J, Meng Z, et al. Effect of timosaponin El and E2 on superoxide generation induced by various stimuli in human neutrophils and on platelet aggregation in human blood [J]. Clin Chim Acta, 2000, 295(1-2): 129-40.
[20] Hoa NK, Phan DV, Thuan ND, et al. Insulin secretion is stimulated by ethanol extract ofA nemarrhena asphodeloides in isolated islet of healthy Wistar and diabetic Goto-Kakizaki rats [J]. Exp Clin Endocrinol Diabetes, 2004, 112(9):520-5.
[21] Miura T, Ichiki H, Iwamoto N, et al. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside [J]. Biol Pharm Bull, 2001, 24(9):1009-11.
[22] 孟志云,李文,徐绥绪,等.知母的皂苷成分[J]药学学报,1999,34(6):451-3.Meng ZY, Li W, Xu SX, et al. Saponins fiom rhizomes of A ne marrhena asphodeloides Bge [J]. Yao Xue Xue Bao, 1999, 34(6):451-3.
[23] Zhang Y, Champagne N, Beitel LK, et al. Estrogen and androgen protection of human neurons against intracellular amyloid betal-42 toxicity through heat shock protein 70[J]. J Neurosci, 2004, 24(23): 5315-21.
[24] Mattson MP, Cheng B, Davis D, et al. β-amyloid peptides desta bilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity[J]. J Neurosci, 1992, 12(2): 376-89.
[25] Varadarajan S, Kanski J, Aksenova M, et al. Differen mechanism of oxidative stress and neurotoxicity for Alzheimer’s A beta(1-42) and A beta(25-35)[J]. J Am Chem Soc, 2001, 123(24): 5625-31.
[26] Giovannelli L, Casamenti F, Scali C, et al. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis [J]. Neuroscience, 1995, 66(4): 781-92.
[27] Nabeshima T, Nitta A. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats [J]. Tohoku J Exp Med,1994, 174(3): 241-9.
[28] Frautschy SA, Yang F, Calderon L. Rodent models of Alzheimer’s disease: rat Abeta infusion approach to amyloid deposits [J]. Neurobiol Aging, 1996, 17(2): 311-21.
[29] Paxinos G, Watson C. The rat brain in stereotaxic coordinates [M]. Sydney: Academic Press, 1982.22.
[30] Morris R. Developments of a water-maze procedure for studying spatial learning in the rat [J]. J Neurosci Methods, 1984, 11(1): 47-60.
[31] Song X, Bao M, Li D. Advanced glycation in D-galactose induced mouse aging model[J]. J Horm Metab Res, 1999, 31(3): 278-82.
[32] Coyle JT, Puttfarcken P. Stress, glutamate and neurodegenerative disorders[J]. Science, 1993, 262(5134): 689-95.
[33] Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and con sequences involving amyloid beta-peptide-associated free radical oxidative stress[J]. Free Radic Biol Med, 2002, 32(11): 1050-60.
[34] Varadarajan S, Yatin S, Aksenova M, et al. Review: Alzheimer’s amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity [J]. J Struct Biol, 2000, 130(2-3): 184-208.
[35] Esterbauer H, Schaur R, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes [J]. Free Radic Biol Med, 1991, 11(1): 81-128.
[36] Marcus DL, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease [J].Exp Neurol, 1998, 150(1): 40-4.